What is the best treatment for bacterial conjunctivitis (pink eye)?

Treatment of Bacterial Conjunctivitis (Pink Eye)

For uncomplicated bacterial conjunctivitis, prescribe a topical fluoroquinolone such as moxifloxacin 0.5% three times daily for 5-7 days, which provides broad-spectrum coverage against the most common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. 1, 2

First-Line Treatment Algorithm

Mild to Moderate Bacterial Conjunctivitis

• Topical moxifloxacin 0.5% is the preferred first-line agent, dosed as one drop in the affected eye three times daily for 7 days, offering superior gram-positive coverage including activity against some methicillin-resistant S. aureus strains. 1, 2
• Alternative fluoroquinolones include levofloxacin, gatifloxacin, ciprofloxacin, or besifloxacin, all effective against common bacterial pathogens with no single agent demonstrating clinical superiority. 1, 3
• If fluoroquinolones are unavailable or cost-prohibitive, second-line options include topical gentamicin, tetracycline, or ofloxacin 0.3% four times daily for 5-7 days. 1, 3

Clinical Benefits of Topical Antibiotics

• Topical antibiotics accelerate clinical and microbiological remission, with cure rates of 68% versus 55% with placebo by days 4-9, allowing faster return to school or work. 1, 3
• Treatment shortens symptom duration from 6-10 days (natural resolution) to 3-5 days with antibiotics, and reduces transmissibility during the contagious period. 1, 4

Special Populations and Circumstances

Contact Lens Wearers

• Reserve fluoroquinolones (ofloxacin or ciprofloxacin) specifically for contact lens wearers due to higher risk of Pseudomonas aeruginosa infection requiring more aggressive anti-pseudomonal coverage. 1, 3

Suspected MRSA Infection

• If no clinical improvement occurs within 48-72 hours of fluoroquinolone therapy, consider MRSA conjunctivitis and obtain conjunctival cultures. 1, 3
• MRSA isolates are generally resistant to fluoroquinolones and aminoglycosides but remain susceptible to vancomycin; compounded topical vancomycin may be required. 1, 3
• Consider MRSA particularly in nursing home residents, patients with recent healthcare exposure, or community-acquired infections with treatment failure. 1

Gonococcal Conjunctivitis (Requires Systemic Therapy)

• Topical antibiotics alone are insufficient—systemic therapy is mandatory. 1, 5, 3
• Obtain conjunctival cultures and Gram staining before initiating treatment. 1, 5
• Adult treatment: Ceftriaxone 250 mg IM single dose plus azithromycin 1 g oral single dose. 1
• Add saline lavage for comfort and faster inflammation resolution. 1, 3
• Requires daily monitoring until complete resolution to prevent corneal perforation, which can occur within 24 hours if untreated. 1

Chlamydial Conjunctivitis (Requires Systemic Therapy)

• Topical therapy alone is inadequate—systemic antibiotics are required because >50% of infants have concurrent infection at other sites (nasopharynx, lungs). 1, 5, 3
• Adult treatment: Azithromycin 1 g oral single dose or doxycycline 100 mg oral twice daily for 7 days. 1
• Neonatal treatment: Erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days. 1
• Re-evaluate after treatment completion; failure rates approach 19%. 1
• Screen for concurrent genital infections and treat sexual partners. 1

When NOT to Use Antibiotics

Viral Conjunctivitis

• Avoid topical antibiotics entirely—they provide no benefit, cause unnecessary adverse effects, promote resistance, and add cost. 1, 5, 6
• Management is supportive only: refrigerated preservative-free artificial tears four times daily, cold compresses, and strict hand hygiene. 1, 5
• Viral conjunctivitis is self-limited and typically resolves in 7-14 days without treatment. 1, 6

Allergic Conjunctivitis

• Do not prescribe antibiotics—use topical antihistamines with mast cell-stabilizing properties as first-line therapy. 1
• Itching is the hallmark symptom distinguishing allergic from bacterial conjunctivitis. 1, 6

Critical Red Flags Requiring Immediate Ophthalmology Referral

Refer urgently if any of the following are present: 1, 5, 3

• Visual loss or decreased visual acuity
• Moderate to severe eye pain (beyond mild irritation)
• Severe purulent discharge suggesting gonococcal infection
• Corneal involvement (opacity, infiltrate, or ulcer)
• Conjunctival scarring
• Lack of response after 3-4 days of appropriate topical therapy
• History of herpes simplex virus eye disease
• Immunocompromised state
• Neonatal conjunctivitis (requires systemic treatment coordinated with pediatrician)

Follow-Up Strategy

• Instruct patients to return in 3-4 days if no improvement is observed. 1, 5, 3
• At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy. 1, 3
• Signs of positive response include reduced pain and discharge, decreased eyelid edema or conjunctival injection, and improved clinical appearance. 1

Important Clinical Pitfalls to Avoid

Never Use Combination Antibiotic-Steroid Drops (e.g., Tobradex) Without Excluding Viral Infection

• Topical corticosteroids are absolutely contraindicated in herpes simplex virus conjunctivitis as they potentiate viral replication and worsen infection, potentially causing corneal perforation. 1, 5, 7
• Corticosteroids prolong adenoviral infections and increase viral shedding. 1
• Before considering any steroid use, definitively rule out viral conjunctivitis by looking for watery discharge, follicular reaction, and preauricular lymphadenopathy. 1

Do Not Prescribe Oral Antibiotics for Routine Bacterial Conjunctivitis

• Oral antibiotics (e.g., Augmentin) cannot achieve therapeutic concentrations in the conjunctiva and are reserved exclusively for gonococcal and chlamydial conjunctivitis. 1
• Unnecessary systemic antibiotic exposure promotes resistance and causes adverse effects (GI upset, drug interactions, C. difficile risk) that outweigh any theoretical benefit. 1

Consider Sexual Abuse in Children

• In preadolescent children with gonococcal or chlamydial conjunctivitis, sexual abuse must be considered and documented by standard culture. 1, 5

Infection Control Measures

• Counsel patients on strict hand hygiene with soap and water to prevent transmission. 1, 5
• Advise avoiding close contact for 7-14 days from symptom onset in viral conjunctivitis. 1
• Recommend avoiding eye rubbing, using separate towels, and discarding multiple-dose eyedrop containers to avoid cross-contamination. 1
• Patients should not wear contact lenses if they have signs or symptoms of bacterial conjunctivitis. 2

Alternative When Antibiotics Are Unavailable

• Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics for bacterial conjunctivitis and is a viable option in settings with limited antibiotic access. 1, 3
• Mild bacterial conjunctivitis is self-limited in immunocompetent patients, with 64% resolving spontaneously by days 6-10 without treatment. 1, 6